Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The Prevalent, Features and Prognostic Impact of Deletion p16 in Patients with Adult Acute Lymphoblastic Leukemia

Na Xu, Yulin Li, Xuan Zhou, Liu Xiaoli, MD, Hongsheng Zhou, MDPhD, Fen Huang, Bing Xu, MD, Qifa Liu, MD, Jing Sun, MD, Ru Feng, MD, Fanyi Meng, MD

Blood (2014) 124 (21): 5351.

https://doi.org/10.1182/blood.V124.21.5351.5351

Published: 2014

Journal Articles

Long-Term Use of Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Chinese Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): MM-024 Expanded Access Program (EAP)

Xin Du, MD, Jie Jin, MD, Zhen Cai, MD, Fangping Chen, MD, Dao-bin Zhou, MD, Li Yu, MD, Xiaoyan Ke, MD PhD, Xiao Li, MD PhD, Depei Wu, MD, Fanyi Meng, MD, Dena DeMarco, Jingshan Zhang, PhD, Jay Mei, MD, Jian Hou, MD PhD

Blood (2014) 124 (21): 5737.

https://doi.org/10.1182/blood.V124.21.5737.5737

Published: 2014

Journal Articles

Imatinib Mesylate Versus Allogeneic Hematopoietic Stem Cell Transplantation For Patients With Chronic Myeloid Leukemia In Chronic Phase

Liu Xiaoli, MD,, Guanlun Gao, Xuan Zhou, Na Xu, Yajuan Xiao, Rui Cao, Changxin Yin, Hongsheng Zhou, Yongqiang Wei, Yu Zhang, Dan Xu, Bing Xu, MD,, Ru Feng, MD,, Qifa Liu, MD,, Jing Sun, MD, Fanyi Meng, MD

Blood (2013) 122 (21): 5518.

https://doi.org/10.1182/blood.V122.21.5518.5518

Published: 2013

Journal Articles

The MM-021 Trial Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma: Impact Of Prior Therapies On Efficacy and Safety

Jie Jin, MD, Xin Du, MD, Zhen Cai, MD, Fangping Chen, MD, Dao-bin Zhou, MD, Li Yu, MD, Xiao Li, MD, PhD, Depei Wu, MD, Fanyi Meng, MD, Huisheng Ai, MMed, Jianmin Wang, MD, Jingshan Zhang, PhD, Honeylet Wortman-Vayn, Jay Mei, MD, Jian Hou, MD, PhD

Blood (2013) 122 (21): 3227.

https://doi.org/10.1182/blood.V122.21.3227.3227

Published: 2013

Journal Articles

ANKL Is Strongly EBV-Related, Frequent In Chromosome Aberrations and Gene Mutations, LMP2A/LMP1-CDK6-MDM2-CD44-Positive and Might Be Sensitive To L-Asparaginase-Containing Regimen

Blood (2013) 122 (21): 3012.

https://doi.org/10.1182/blood.V122.21.3012.3012

Published: 2013

Journal Articles

Study Of Stem Cell Homing and Donor-Recipient Cellular Interaction In Allogenic Hematopoietic Stem Cell Transplantation Mice Model

Qianli Jiang, Ph.D&MD, Yan-yan Ye, MD, Le-zhong Yuan, MD, Shan Jiang, Ph.D&MD, Jing Sun, MD, Pei-ran Zhao, Chang-xin Yin, Qing Mai, Kefeng Shen, MD, Hao Huang, MD, Yang Lu, MD, Fanyi Meng, MD, Qi-Fa Liu

Blood (2013) 122 (21): 5424.

https://doi.org/10.1182/blood.V122.21.5424.5424

Published: 2013

Journal Articles

Continuous Intravenous Injection Of Mesna Can Reduce Acute Hemorrhagic Cystitis Occurrence Rate In Hematopoietic Stem Cell Transplantation: 359 Allo-HSCT Cases Report

Blood (2013) 122 (21): 4556.

https://doi.org/10.1182/blood.V122.21.4556.4556

Published: 2013

Journal Articles

Efficacy and Safety Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma (RRMM) and Renal Impairment: MM-021 Subgroup Analysis

Dao-bin Zhou, MD, Li Yu, MD, Xin Du, MD, Jie Jin, MD, Zhen Cai, MD, Fangping Chen, MD, Xiao Li, MD, PhD, Depei Wu, MD, Fanyi Meng, MD, Huisheng Ai, MMed, Jingshan Zhang, PhD, Honeylet Wortman-Vayn, Jay Mei, MD, Jianmin Wang, MD, Jian Hou, MD, PhD

Blood (2013) 122 (21): 5374.

https://doi.org/10.1182/blood.V122.21.5374.5374

Published: 2013

Journal Articles

The Molecular Mechanisms of Serotonin in the Regulation of Megakaryocytopoiesis and TPO Production

Mo Yang, M.D.Ph.D, Fanyi Meng, MD, Jie Yu Ye, Yue Xu, Bin Xiao, Beng Chong, MBBS, PhD

Blood (2012) 120 (21): 3347.

https://doi.org/10.1182/blood.V120.21.3347.3347

Published: 2012

Journal Articles

Role of PDGF/PDGFR in Regulation of Thrombopoiesis: A Possible Explanation for Imatinib Mesylate-Induced Thrombocytopenia in the Treatment of CML

Mo Yang, M.D.Ph.D, Fanyi Meng, MD, Jie yu Ye, Yue Xu, Bin Xiao, Beng Chong, MBBS, PhD

Blood (2012) 120 (21): 3348.

https://doi.org/10.1182/blood.V120.21.3348.3348

Published: 2012

Journal Articles

APS From the Root of Angelica Sinesis Promotes Megakaryocytopoiesis and Thrombopoiesis Through PI3k/Akt Pathway

Mo Yang, M.D.Ph.D, Fanyi Meng, MD, Jie Yu Ye, Yue Xu, Bin Xiao, Beng Chong, MBBS, PhD, Chang Liu, MD, PhD

Blood (2012) 120 (21): 4648.

https://doi.org/10.1182/blood.V120.21.4648.4648

Published: 2012

Journal Articles

New Method for in Vivo Hematopoiesis Microenvironment Research: Tissue-Engineering-Bone Femur Repairing Model and Semi-Solid Decalcification

Shan Jiang, MD&PhD, Qianli Jiang, MD&PhD, Liqiong Zhu, Feili Chen, M.D., Lezhong Yuan, Peiran Zhao, Mo Yang, M.D.Ph.D, Jing Sun, Fanyi Meng, MD

Blood (2012) 120 (21): 4732.

https://doi.org/10.1182/blood.V120.21.4732.4732

Published: 2012

Journal Articles

A Multi-Center, Open-Label Phase II Study of Lenalidomide Plus Low-Dose Dexamethasone in Chinese Patients with Relapsed/Refractory Multiple Myeloma - the MM-021 Trial

Jian Hou, MD, PhD, Jie Jin, MD, Zhen Cai, Fangping Chen, Li Yu, Dao-bin Zhou, MD, Xiao Li, MD, PhD, Xiaoyan Ke, MD, PhD, Depei Wu, MD, Huisheng Ai, Fanyi Meng, MD, Jianmin Wang, Jay Mei, MD, PhD, Jingshan Zhang, PhD, Honeylet Wortman-Vayn, Xin Du, PhD

Blood (2012) 120 (21): 1864.

https://doi.org/10.1182/blood.V120.21.1864.1864

Published: 2012

Journal Articles

Antithymocyte Globulin (ATG) Plus Cyclosporine (CsA) and Combined with Cord Blood Infusion Is Superior to ATG Plus Csa for the Treatment of Severe Aplastic Anemia

Zhiping Fan, Qifa Liu, Jing Sun, Qianli Jiang, Fen Huang, M.D., Xian Zhang, Dan Xu, Hongsheng Zhou, Bing Xu, M.D. PhD, Fanyi Meng, MD, Xiaoli Liu, MD, Ru Feng, M.D.

Blood (2012) 120 (21): 4397.

https://doi.org/10.1182/blood.V120.21.4397.4397

Published: 2012

Journal Articles

Phase 2 Study of Dasatinib in Chinese Patients (Pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) or Advanced Phase Who Are Resistant to or Intolerant of Imatinib (IM)

Jianxiang Wang, MD, Xiaojun Huang, Jianda Hu, PhD, Jianyong Li, MD, PhD, Jie Jin, MD, Fanyi Meng, MD, Zhixiang Shen, MD, Ting Liu, MD, Depei Wu, MD, Jianmin Wang

Blood (2011) 118 (21): 4434.

https://doi.org/10.1182/blood.V118.21.4434.4434

Published: 2011

Journal Articles

An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in Chinese Population.

Yang Shen, MD, Zhixiang Shen, MD, Bin Jiang, MD, Jian Hou, MD, Rong Zhan, MD, Lugui Qiu, MD, Yongji Wu, MD, Jie Jin, MD, Juan Li, MD, Fanyi Meng, MD, Ping Zou, MD, Ting Liu, MD, Jianyong Li, MD, Chun Wang, MD, Depai Wu, MD, Jun Ma, MD

Blood (2007) 110 (11): 4816.

https://doi.org/10.1182/blood.V110.11.4816.4816

Published: 2007

Journal Articles

Comparison of Therapeutic Effect between Related Donor and Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) in the Treatment of Leukemia.

Qifa Liu, MD, Kai Yang, MD, Zhiping Fan, MD, Jing Sun, MD, Dan Xu, MD, Yongqiang Wei, MD, Yu Zhang, MD, Fanyi Meng, MD

Blood (2006) 108 (11): 5389.

https://doi.org/10.1182/blood.V108.11.5389.5389

Published: 2006

Journal Articles

Clinical Effects of Unrelated-Donor or Related-Donor Hematopoietic Stem Cell Transplantation for Leukemia.

Qifa Liu, MD, Jing Sun, MD, Dan Xu, MD, Yongqiang Wei, MD, Yu Zhang, MD, Changxiong Ye, MD, Fanyi Meng, MD

Blood (2005) 106 (11): 5436.

https://doi.org/10.1182/blood.V106.11.5436.5436

Published: 2005

NARROW

The Prevalent, Features and Prognostic Impact of Deletion p16 in Patients with Adult Acute Lymphoblastic Leukemia

Long-Term Use of Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Chinese Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): MM-024 Expanded Access Program (EAP)

Imatinib Mesylate Versus Allogeneic Hematopoietic Stem Cell Transplantation For Patients With Chronic Myeloid Leukemia In Chronic Phase

The MM-021 Trial Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma: Impact Of Prior Therapies On Efficacy and Safety

ANKL Is Strongly EBV-Related, Frequent In Chromosome Aberrations and Gene Mutations, LMP2A/LMP1-CDK6-MDM2-CD44-Positive and Might Be Sensitive To L-Asparaginase-Containing Regimen

Study Of Stem Cell Homing and Donor-Recipient Cellular Interaction In Allogenic Hematopoietic Stem Cell Transplantation Mice Model

Continuous Intravenous Injection Of Mesna Can Reduce Acute Hemorrhagic Cystitis Occurrence Rate In Hematopoietic Stem Cell Transplantation: 359 Allo-HSCT Cases Report

Efficacy and Safety Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma (RRMM) and Renal Impairment: MM-021 Subgroup Analysis

The Molecular Mechanisms of Serotonin in the Regulation of Megakaryocytopoiesis and TPO Production

Role of PDGF/PDGFR in Regulation of Thrombopoiesis: A Possible Explanation for Imatinib Mesylate-Induced Thrombocytopenia in the Treatment of CML

APS From the Root of Angelica Sinesis Promotes Megakaryocytopoiesis and Thrombopoiesis Through PI3k/Akt Pathway

New Method for in Vivo Hematopoiesis Microenvironment Research: Tissue-Engineering-Bone Femur Repairing Model and Semi-Solid Decalcification

A Multi-Center, Open-Label Phase II Study of Lenalidomide Plus Low-Dose Dexamethasone in Chinese Patients with Relapsed/Refractory Multiple Myeloma - the MM-021 Trial

Antithymocyte Globulin (ATG) Plus Cyclosporine (CsA) and Combined with Cord Blood Infusion Is Superior to ATG Plus Csa for the Treatment of Severe Aplastic Anemia

Phase 2 Study of Dasatinib in Chinese Patients (Pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) or Advanced Phase Who Are Resistant to or Intolerant of Imatinib (IM)

An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in Chinese Population.

Comparison of Therapeutic Effect between Related Donor and Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) in the Treatment of Leukemia.

Clinical Effects of Unrelated-Donor or Related-Donor Hematopoietic Stem Cell Transplantation for Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only